NEW YORK, March 30, 2022 (World NEWSWIRE) — Moore Kuehn, PLLC, a securities regulation company positioned on Wall Street, is investigating irrespective of whether particular officers and directors of Progyny, Inc. (NASDAQ: PGNY), PTC Therapeutics, Inc. (NASDAQ: PTCT), Inexperienced Dot Company (NYSE: GDOT), and Reata Prescribed drugs, Inc. (NASDAQ: RETA) breached their fiduciary responsibilities to shareholders. The investigation worries possible self-working. Shareholders may well be entitled to damages and company governance reforms.
If you possess PGNY, PTCT, GDOT, or RETA make sure you contact Justin Kuehn, Esq. by email at [email protected] or phone at (212) 709-8245. The session and situation are no cost with no obligation to you. Moore Kuehn pays all scenario charges and does not demand its trader customers. Shareholders must speak to the agency instantly as there could be restricted time to implement your rights.
Moore Kuehn is a 5-star Google client-rated New York City regulation organization with lawyers symbolizing traders and buyers in litigation involving securities rules, fraud, breaches of fiduciary responsibilities, and other promises. For more details about Moore Kuehn, make sure you stop by http://www.moorekuehn.com/observe/new-york-securities-litigation/.
Attorney promoting. Prior effects do not ensure equivalent outcomes.
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Avenue, 8th Floor
New York, New York 10005